← Research status explorer
Rebuild / Repair & longevity
Thymosin Alpha-1
Also known as: Zadaxin
Current research status
Phase 3
Indication-specific clinical development
Preclinical
Phase 1
Phase 2
Phase 3
Approved Molecule*
Overview
Thymosin Alpha-1 is an immune-modulating thymic peptide studied for chronic infections, certain cancers and immune support. It is marketed in a number of countries as Zadaxin, though it does not hold FDA approval in the United States. Indication-specific Phase 3 trials have been conducted outside the US, including in hepatitis and sepsis-related research.
Last reviewed: September 2026
